Estimates from IQVIA's LAAD data for CABENUVA. Based on analysis of national pharmacy data, for prescriptions filled by a specialty pharmacy between Feb 2022 and Jan 2023. The analysis includes only retail claims that were paid and for which licensed data about the transaction was available. Data does not include buy and bill medical benefit claims. Additional costs may be incurred for product administration.